Community Care Intervention for COVID-19 Vaccination
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if working with community health workers can help more adults with chronic illnesses stay current on their COVID-19 and flu vaccines. Participants will either receive regular care or work with a community health worker who provides up to three sessions in English or Spanish to address reasons for not being vaccinated. The trial seeks adults who have received a COVID-19 vaccine before but are not currently up to date and have been diagnosed with conditions such as high blood pressure, diabetes, asthma, being overweight, or mental health issues like depression or anxiety. As an unphased trial, this study offers a unique opportunity to contribute to important research that could enhance community health strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but it's best to confirm with the trial organizers.
What prior data suggests that the Community Health Worker Intervention is safe?
Research has shown that programs involving community health workers (CHWs) are generally safe. These programs help people learn about vaccines and make healthier choices. In a previous study, using CHWs reduced hospital stays by 34% compared to regular care, indicating a positive safety profile. No specific reports of negative effects have been linked to CHW programs, suggesting they are well-tolerated. By focusing on education and support rather than medical treatments or drugs, these programs lower the risk of side effects.12345
Why are researchers excited about this trial?
Researchers are excited about the Community Health Worker (CHW) intervention for COVID-19 vaccination because it takes a unique approach by focusing on personalized psychoeducational sessions. Unlike existing vaccines that rely on biological mechanisms to protect against the virus, the CHW intervention targets behavioral aspects of vaccination uptake using motivational interviewing techniques. This method addresses specific reasons why individuals might be hesitant or delayed in getting vaccinated, providing tailored support in either English or Spanish. By bridging the gap between vaccine availability and actual vaccination behavior, this approach could significantly enhance public health efforts in increasing vaccination rates.
What evidence suggests that the CHW intervention is effective for increasing COVID-19 vaccination rates?
Research has shown that community health workers (CHWs) can significantly increase vaccination rates. In this trial, participants in the Community Health Worker (CHW) Intervention arm will receive up to three psychoeducational sessions to address specific reasons for not being up to date with their COVID-19 vaccine. One study found that CHWs shared vaccine information with their community, increasing the number of vaccinated individuals from 44% to 76% in just one year. Another study in New York City demonstrated how CHWs improved vaccination, testing, and treatment during the COVID-19 pandemic. These findings suggest that CHWs effectively encourage vaccinations by providing personalized education and support.12678
Who Is on the Research Team?
Marielena Lara, MD, MPH
Principal Investigator
RAND
Lisa Meredith, PhD
Principal Investigator
RAND
Jonathan Tobin, PhD
Principal Investigator
Clinical Directors Network
Andrea Cassells, MPH
Principal Investigator
Clinical Directors Network
Are You a Good Fit for This Trial?
This trial is for adults over 18 who speak English or Spanish and can complete an assessment without confusion. It's not for those unwilling to consent, acutely sick individuals, or people at high risk of suicide.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the CHW group receive up to 3 psychoeducational sessions to address barriers to COVID-19 and influenza vaccination.
Follow-up
Participants are monitored for vaccine acceptance and uptake at 3 months.
What Are the Treatments Tested in This Trial?
Interventions
- CHW-VB
Find a Clinic Near You
Who Is Running the Clinical Trial?
RAND
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Clinical Directors Network
Collaborator